A peptide named humanin initially identified from surviving neurons in patients with Alzheimer’s disease (AD), was described as a direct enhancer of CMA that acts by increasing substrate binding and translocation into lysosomes [37]. Here, MT-RNR2 is linked to Alzheimer disease.